11q13 is a susceptibility locus for hormone receptor positive breast cancer
暂无分享,去创建一个
Patrick Neven | Michael Jones | Michael Bremer | Julian Peto | Thomas Brüning | Kamila Czene | Ute Hamann | Peter Devilee | Gord Glendon | Alfons Meindl | Katarzyna Durda | Thilo Dörk | Barbara Burwinkel | Katri Pylkäs | Mervi Grip | Arto Mannermaa | Paolo Peterlongo | Annegien Broeks | Hermann Brenner | Per Hall | Børge G. Nordestgaard | Heli Nevanlinna | Angela Cox | Robert Winqvist | Annika Lindblom | Anthony Swerdlow | Vessela Kristensen | Pascal Guénel | Kristiina Aittomäki | Carl Blomqvist | Vesa Kataja | Christa Stegmaier | Volker Arndt | Argyrios Ziogas | Carmel Apicella | Jolanta Lissowska | Ian Tomlinson | Nicola Miller | Andreas Schneeweiss | Laura Baglietto | Olivia Fletcher | Nichola Johnson | Sten Cornelissen | Stefan Nickels | Paolo Radice | Anna Jakubowska | Jan Lubinski | Hiltrud Brauch | Elinor Sawyer | Diether Lambrechts | Alan Ashworth | Sarah Schott | Christof Sohn | Peter Hillemanns | Gianluca Severi | Javier Benítez | Daehee Kang | Puttisak Puttawibul | Rebecca Hein | Katarzyna Jaworska | Jianjun Liu | Artitaya Lophatananon | Therese Truong | S. Cross | R. Schulz-Wendtland | M. Beckmann | P. Fasching | A. Ashworth | A. Børresen-Dale | D. Noh | K. Czene | P. Hall | J. Olson | F. Couch | A. Schneeweiss | H. Brenner | J. Chang-Claude | S. Chanock | M. García-Closas | J. Benítez | P. Neven | G. Giles | G. Severi | J. Hopper | E. John | T. Dörk | M. Southey | A. Lophatananon | A. Cox | D. Easton | Chen-Yang Shen | A. Broeks | P. Pharoah | D. Lambrechts | J. Peto | E. Khusnutdinova | N. Orr | H. Brauch | M. Sherman | V. Kristensen | C. Sohn | P. Hillemanns | A. Ziogas | H. Anton-Culver | P. Guénel | A. Dunning | Pei-Ei Wu | O. Fletcher | N. Johnson | G. Chenevix-Trench | S. Bojesen | B. Nordestgaard | J. Lissowska | H. Nevanlinna | D. Kang | K. Yoo | Jianjun Liu | N. Bogdanova | P. Schürmann | R. Tollenaar | P. Devilee | I. Brock | R. Milne | C. Justenhoven | U. Hamann | Y. Ko | J. Beesley | Xiaoqing Chen | A. Mannermaa | V. Kosma | V. Kataja | J. Hartikainen | N. Miller | M. Kerin | K. Muir | A. Lindblom | M. Schmidt | I. D. S. Silva | T. Muranen | K. Aittomäki | C. Blomqvist | R. Hein | A. Meindl | R. Schmutzler | Xianshu Wang | R. Paridaens | S. Nickels | D. Flesch‐Janys | T. Truong | F. Menegaux | B. Burwinkel | M. P. Zamora | J. I. Pérez | E. Sawyer | I. Tomlinson | I. Andrulis | G. Glendon | A. Mulligan | S. Margolin | M. Hooning | G. Dite | C. Apicella | L. Baglietto | A. Ekici | H. Müller | V. Arndt | C. Stegmaier | A. Swerdlow | Michael Jones | R. Winqvist | K. Pylkäs | A. Jukkola-Vuorinen | M. Grip | T. Brüning | P. Radice | P. Peterlongo | S. Manoukian | C. Seynaeve | A. Jakubowska | J. Lubiński | Katarzyna Jaworska | K. Durda | N. Antonenkova | H. Wildiers | M. Bermisheva | M. Bremer | U. Eilber | S. Wang-gohrke | C. Bartram | M. Hou | Z. Fredericksen | M. Humphreys | J. Karstens | S. Cornelissen | G. Elliott | Jyh‐cherng Yu | A. Miron | L. Bernard | S. Schott | Kconfab Investigators | E. Cordina-Duverger | Darya Prokofieva | Sara Margolin | kConFab Investigators | Nicholas Orr | Siranoush Manoukian | Robert Paridaens | Hans Wildiers | F. Marmé | Xiaoqing Chen | Jenny Chang‐Claude | Douglas F. Easton | Jonathan Beesley | Elza Khusnutdinova | Christina Justenhoven | Heiko Müller | G. G. Alnæs | Stephen J. Chanock | Irene L. Andrulis | Marina Bermisheva | Anna Marie Mulligan | Darya Prokofieva | Peter Schürmann | Melissa Southey | Graham Giles | Veli‐Matti Kosma | Montserrat García‐Closas | Loris Bernard | Alexander Miron | Zachary Fredericksen | Xianshu Wang | Mark E. Sherman | Florence Menegaux | Teresa Selander | John L. Hopper | Michael Kerin | Graeme Elliott | Esther M. John | Suthee Rattanamongkongul | Matthias W. Beckmann | Arif B. Ekici | Anne‐Lise Børresen‐Dale | Janet E. Olson | Peter A. Fasching | Fergus J. Couch | P. Puttawibul | Hoda Anton‐Culver | Jean Wang | Simon S. Cross | Alison M. Dunning | Roger L. Milne | Stig E. Bojesen | Jaana M. Hartikainen | Yon‐Dschun Ko | Emilie Cordina‐Duverger | Melissa C. Southey | Dieter Flesch‐Janys | Georgia Chenevix‐Trench | Marjanka K. Schmidt | Charlotte Lanng | Manjeet K. Humphreys | Gillian S. Dite | Richard van Hien | M. Pilar Zamora | José Ignacio Arias Pérez | Ursel Eilber | Shan Wang‐Gohrke | Arja Jukkola‐Vuorinen | Chen‐Yang Shen | Jyh‐Cherng Yu | Pei‐Ei Wu | Ming‐Feng Hou | Kenneth R. Muir | Federik Marmé | Betul T. Yesilyurt | Claus R. Bartram | Rita K. Schmutzler | Ian W. Brock | Ruediger Schulz‐Wendtland | Isabel dos Santos Silva | Taru A. Muranen | Natalia V. Bogdanova | Natalia N. Antonenkova | Yuri I. Rogov | Johann H. Karstens | Shamil Gancev | Grethe Grenaker Alnæs | Robert A.E.M. Tollenaar | Caroline M. Seynaeve | Maartje J. Hooning | Keun‐Young Yoo | Dong‐Young Noh | Paul D.P. Pharoah | C. Lanng | B. T. Yesilyurt | Jean Wang | Suthee Rattanamongkongul | R. van Hien | T. Selander | Y. Rogov | S. Gancev
[1] W. Willett,et al. A genome-wide association study identifies alleles in FGFR 2 associated with risk of sporadic postmenopausal breast cancer , 2012 .
[2] Patrick Neven,et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. , 2011, Human molecular genetics.
[3] D. Yee,et al. Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer. , 2011, Endocrine-related cancer.
[4] O. Gaye,et al. Breast cancer risk by occupation and industry: analysis of the CECILE study, a population-based case-control study in France. , 2011, American journal of industrial medicine.
[5] Victoria L. Cafourek,et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.
[6] Talin Haritunians,et al. Variants in ZNF365 isoform D are associated with Crohn's disease , 2011, Gut.
[7] Nathaniel D. Heintzman,et al. 9p21 DNA variants associated with Coronary Artery Disease impair IFNγ signaling response , 2011, Nature.
[8] Peter Kraft,et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk , 2011, Nature Genetics.
[9] Christiana Kartsonaki,et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.
[10] Deborah Hughes,et al. Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.
[11] J. Diehl,et al. Nuclear cyclin D1: An oncogenic driver in human cancer , 2009, Journal of cellular physiology.
[12] Melissa Bondy,et al. Genome-wide association study identifies five susceptibility loci for glioma , 2009, Nature Genetics.
[13] M. Beckmann,et al. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. , 2009, Journal of the National Cancer Institute.
[14] Alexander R. Pico,et al. Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility , 2009, Nature Genetics.
[15] T. Spector,et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi , 2009, Nature Genetics.
[16] M. Thun,et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.
[17] W. Willett,et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) , 2009, Nature Genetics.
[18] A. Jakubowska,et al. Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? , 2009, European journal of cancer.
[19] Giu-Cheng Hsu,et al. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. , 2009, Carcinogenesis.
[20] N. Miller,et al. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer , 2009, Breast Cancer Research and Treatment.
[21] P. Radice,et al. SNPs in ultraconserved elements and familial breast cancer risk. , 2009, Carcinogenesis.
[22] T. Dörk,et al. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer , 2009, Breast Cancer Research and Treatment.
[23] N. Miller,et al. Low penetrance breast cancer predisposition SNPs are site specific , 2009, Breast Cancer Research and Treatment.
[24] J. Kładny,et al. Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology , 2009, Breast Cancer Research and Treatment.
[25] P. Bugert,et al. SNPs in ultraconserved elements and familial breast cancer risk. , 2009, Carcinogenesis.
[26] P. Radice,et al. Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases , 2009, Breast Cancer Research and Treatment.
[27] J. Chang-Claude,et al. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy , 2008, International journal of cancer.
[28] Elmar Bucher,et al. Genome‐wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients , 2008, Genes, chromosomes & cancer.
[29] H. Brenner,et al. Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study , 2008, PloS one.
[30] A. Sigurdsson,et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.
[31] O. Bernard,et al. Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation , 2008, Leukemia.
[32] B. van Calster,et al. In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] M. Bani,et al. Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer , 2008, Journal of Cancer Research and Clinical Oncology.
[34] E. van Limbergen,et al. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] M. Bani,et al. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients , 2008, Breast Cancer Research and Treatment.
[36] T. Illig,et al. The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer , 2008, Breast Cancer Research and Treatment.
[37] W. Han,et al. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk , 2008, Breast Cancer Research and Treatment.
[38] A. Whittemore,et al. Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from Two Australian Studies and an Additional Validation Set , 2007, Cancer Epidemiology Biomarkers & Prevention.
[39] J. Klijn,et al. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases , 2007, Breast Cancer Research.
[40] Chen-Yang Shen,et al. Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex , 2007, Cancer Epidemiology Biomarkers & Prevention.
[41] D. Gudbjartsson,et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.
[42] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[43] M. McCarthy,et al. Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.
[44] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[45] Douglas B. Evans,et al. Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians , 2007, Clinical Cancer Research.
[46] Katri Pylkäs,et al. A recurrent mutation in PALB2 in Finnish cancer families , 2007, Nature.
[47] R. Vierkant,et al. A Comprehensive Examination of CYP19 Variation and Breast Density , 2007, Cancer Epidemiology Biomarkers & Prevention.
[48] S. Bojesen,et al. Increased risk of breast cancer associated with CHEK2*1100delC. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] J. Peterse,et al. Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] Chen-Yang Shen,et al. Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex , 2007, Cancer Epidemiology, Biomarkers and Prevention.
[51] Paul D.P. Pharoah,et al. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. , 2007, Journal of the National Cancer Institute.
[52] Genica,et al. Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium , 2006 .
[53] Joaquín Dopazo,et al. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping. , 2006, Cancer research.
[54] A. Ashworth,et al. Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. , 2006, Journal of the National Cancer Institute.
[55] A. Mannermaa,et al. Refinement of the 22q12-q13 Breast Cancer–Associated Region: Evidence of TMPRSS6 as a Candidate Gene in an Eastern Finnish Population , 2006, Clinical Cancer Research.
[56] P. Bugert,et al. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. , 2006, Carcinogenesis.
[57] S. Chanock,et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses , 2006, Human Genetics.
[58] John L Hopper,et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource , 2006, Breast Cancer Research.
[59] W. Han,et al. Genetic Polymorphisms of Ataxia Telangiectasia Mutated and Breast Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.
[60] Päivi Heikkilä,et al. Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients , 2005, International journal of cancer.
[61] D. Easton,et al. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[62] H. Brauch,et al. Factors Modifying the Association Between Hormone-Replacement Therapy and Breast Cancer Risk , 2005, European Journal of Epidemiology.
[63] C. Larsson,et al. Hereditary breast cancer in sweden: a predominance of maternally inherited cases , 2005, Breast Cancer Research and Treatment.
[64] B. Ponder,et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. , 2004, Journal of the National Cancer Institute.
[65] M. Schutte,et al. Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant , 2004, Journal of Medical Genetics.
[66] A. Lindblom,et al. BRCA1 mutations in a population-based study of breast cancer in Stockholm County. , 2004, Genetic testing.
[67] Norman Boyd,et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.
[68] J. Chang-Claude,et al. Breastfeeding and breast cancer risk by age 50 among women in Germany , 2000, Cancer Causes & Control.
[69] John L Hopper,et al. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. , 2003, Journal of the National Cancer Institute.
[70] T. Stephenson,et al. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. , 2002, Human molecular genetics.
[71] T. Stephenson,et al. A potential role for the XRCC 2 R 188 H polymorphic site in DNA-damage repair and breast cancer , 2002 .
[72] D. English,et al. The Melbourne Collaborative Cohort Study. , 2002, IARC scientific publications.
[73] T. Dörk,et al. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. , 2001, Cancer research.
[74] K Holli,et al. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. , 2000, Journal of the National Cancer Institute.
[75] A. Ziogas,et al. Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer. , 2000, European journal of cancer.
[76] D. Seminara,et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[77] J. Bartek,et al. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. , 1995, Cancer letters.